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Abstract
We report a case of a patient presenting with clinical, 
radiological and endoscopic features of colitis due 
to a compressive left para-aortic mass. Total open 
surgical excision was performed, which resulted in 
complete resolution of colitis. Histopathology and 
immunohistochemistry revealed benign retroperitoneal 
schwannoma. These neural sheath tumors rarely occur 
in the retroperitoneum. They are usually asymptomatic 
but as they enlarge they may compress adjacent 
structures, which leads to a wide spectrum of non-
specific symptoms, including lumbar pain, headache, 
secondary hypertension, abdominal pain and renal 
colicky pain. CT and MR findings show characteristic 
features, but none are specific. Schwannoma can 
be isolated sporadic lesions, or associated with 
schwannomatosis or neurofibromatosis type Ⅱ (NF2). 
Although they vary in biological and clinical behavior, 
their presence is, in nearly every case, due to alterations 
or absence of the NF2  gene, which is involved in the 
growth regulation of Schwann cells. Both conditions 
were exc luded by thorough mutat ion ana lys is . 
Diagnosis is based on histopathological examination and 
immunohistochemistry. Total excision is therapeutic and 
has a good prognosis. Schwannomatosis and NF2 should 
be excluded through clinical diagnostic criteria. Genetic 
testing of NF2 is probably not justifi ed in the presence of 
a solitary retroperitoneal schwannoma.
© 2007 WJG. All rights reserved.
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INTRODUCTION
Schwannomas or neurilemmomas are encapsulated tumors 
arising from the neural sheath of  peripheral nerves. They 
are usually present in the head and neck or in the upper ex-
tremities, but may appear in the posterior mediastinum and 
more rarely in the retroperitoneum. The latter are often 
found incidentally or may present with vague, non-specifi c 
symptoms if  the tumor is large enough to compress sur-
rounding structures.
We report a case of  a benign retroperitoneal schwanno-
ma with an unusual clinical presentation, its radiological, 
histopathological and genetic features, and its subsequent 
management.
CASE REPORT
A 45-year-old woman was admitted to our emergency de-
partment for severe colicky abdominal pain with nausea 
and vomiting that started about 15 min after her last meal. 
She had no relevant medical history but mentioned hav-
ing had back pain for the last 2 mo, which she thought 
was due to her increasing workload and stress at work. She 
denied having any abdominal problems until that day. On 
clinical examination, the patient was afebrile, pale and un-
comfortable. Blood pressure and heart rate were normal. 
Abdominal examination showed a diffusely tender abdo-
men, more pronounced in the left lower quadrant. She had 
no guarding or rebound. Deep palpation of  the abdomen 
revealed a non-tender, non-pulsatile mass left of  the um-
bilicus. Rectal examination was unremarkable, except for 
the presence of  a little blood. Within the fi rst hour after 
admission, the patient suffered one episode of  diarrhea 
stained with a moderate amount of  fresh blood. Labora-
tory tests showed an increased white blood cell count 
www.wjgnet.com
(WBC) of  18 000 cells/mm³ and C-reactive protein (CRP) 
of  1.1 mg/dL. Other values were within the normal range. 
At this point our differential diagnosis included diverticu-
litis and a contrast-enhanced computed tomodensitometry 
(CT) of  the abdomen was performed. It revealed a diffuse 
infi ltration around the rectum and the sigmoid colon, and 
a thickening of  their walls (Figure 1). No diverticula were 
found. It also showed a well-demarcated, homogeneous, 
left para-aortic mass lying between the lumbar vertebrae 
and the left psoas muscle, which measured  60 × 50 mm 
(Figure 2). With few specifi c fi ndings, the scan was consid-
ered inconclusive.
She was hospitalized and received isotonic fl uid resus-
citation, and intravenous broad-spectrum antibiotics were 
commenced. Symptoms improved rapidly and disappeared 
almost completely 3 d after the initial complaints. During 
her hospital stay, several examinations were performed. 
First, the patient underwent colonoscopy to exclude in-
flammatory bowel disease (IBD). It revealed a diffusely 
edematous, slightly erythematous rectum and sigmoid 
colon, but no erosive or ulcerative lesions. Histopathologi-
cal examination of  biopsies taken during colonoscopy 
showed diffuse edema and signs of  chronic infl ammation, 
characterized by the presence of  mostly lymphocytes and 
polynuclear granulocytes. Granulomas were absent. A few 
cryptic abscesses and zones of  erosion were also found. 
The pathologist’s diagnosis was chronic colitis, more pro-
nounced in the sigmoid colon than the left colon, and 
excluded IBD. In laboratory tests, WBC had fallen to a 
normal value at 9780 cells/mm³ after a rise to 12 000. CRP 
level followed the same course to settle at 1.7 mg/dL, af-
ter it had risen to 10.8. Tumor markers CEA and CA 19.9 
were within the normal range. Magnetic resonance imag-
ing showed the same features as seen with CT scanning
(Figure 3).
Since we believed that the mass caused the patient’s 
signs and symptoms, we opted for open surgical excision. 
We approached the retroperitoneal space through a median 
laparotomy. During exploration and meticulous dissection 
of  the mass, we noticed that it was in close proximity to 
the aorta and left iliac artery and vein, and seemed to arise 
from the left para-aortic sympathetic chain. It also adhered 
partially to the left psoas muscle and to the anterior as-
pect of  the lumbar vertebrae. Complete excision was per-
formed. Perioperative examination of  the mass revealed a 
solid, greyish, spherical tumor with a smooth capsule and a 
heterogeneous core (Figure 4).
The postoperative course was uneventful. We noticed 
that the left leg was slightly warmer and dryer than the 
right, which suggested that we had performed a left lumbar 
sympathectomy, thus in favor of  the excision of  a tumor 
of  neural origin. Microscopic histopathological examina-
tion revealed strings of  spindle cells surrounded by a col-
lagenous stroma that was partially hyalinized and showed 
cystic degeneration in some regions (Figure 5). There was 
some nuclear atypia with very limited mitotic activity, but 
Figure 1  Contrast-enhanced CT scan of the abdomen showing a diffuse infi ltration 
around the rectum and the sigmoid colon, and thickening of their walls.
Figure 2  Well-demarcated, homogeneous mass measuring 60×50 mm in close 
proximity to the left iliac artery, lumbar vertebrae and psoas muscle, on contrast-
enhanced CT scanning.
Figure 3  Coronal T1-weighted MR 
image using gadolinium, showing a 
solid mass with the same features as 
seen with CT scanning.
Figure 4  Perioperative examination of the mass revealed a solid, greyish, ovoid 
tumor with a smooth capsule and a homogeneous yellow core.
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no signs of  malignancy. The tumor tested intensely posi-
tive for S-100 protein, which confi rmed the diagnosis of  
benign schwannoma. The integrity of  the capsule was also 
noted, which confirmed total excision of  the mass. The 
patient was discharged from the hospital on the fi fth post-
operative day.
Six weeks after surgery, she was still symptom free 
and signs of  sympathectomy persisted. A CT scan and 
colonoscopy were performed to evaluate the evolution of  
colitis, which had completely resolved. Further investiga-
tions were performed to exclude neurofibromatosis type 
Ⅱ (NF2) or schwannomatosis. Thorough physical exami-
nation was performed on the patient but no superficial 
tumors were found. Family history for schwannoma or 
meningioma was negative. MRI did not show any tumor 
of  the central nervous system. Furthermore, the presence 
of  a germline NF2 mutation was excluded by thorough 
mutation analysis on DNA extracted from the patient’
s lymphocytes. We performed direct sequencing of  all 
coding exons of  the NF2 gene. Deletion was excluded by 
multiplex ligation-dependent probe amplifi cation (MLPA). 
We concluded that the schwannoma was most likely due to 
a somatic mutation in the NF2 gene.
DISCUSSION
Schwannomas, or neurilemmomas, are tumors arising from 
the Schwann cells of  peripheral nerves[1,2]. They are usually 
found in the head and neck or in the upper extremities. 
Only 1% is found in the retroperitoneum, which accounts 
for 0.5%-1.2% of  all retroperioneal tumors[3,4]. They can be 
isolated as sporadic lesions or associated with schwanno-
matosis or NF2. Although they vary in biological and clini-
cal behavior, their presence is in nearly every case due to 
alterations or absence of  the NF2 gene (located on chro-
mosome 22q12), which codes for merlin, a tumor suppres-
sor protein involved in the growth regulation of  Schwann 
cells, but its exact mechanism has not yet been elucidated. 
Most schwannomas are benign but (although very rarely) 
malignant degeneration can occur, and is usually associated 
with NF2[5]. Patients with benign retroperitoneal schwanno-
mas are predominantly in their second to fi fth decade, and 
women are twice as often affected as men[4,6].
On gross appearance, schwannomas are well-demarcat-
ed, solid tumors with a smooth surface and have an ovoid 
or spherical shape[7]. Sometimes, secondary changes such 
as hemorrhage, cysts and calcification can be present[1]. 
They are usually solitary and slow-growing tumors[1]. The 
retroperitoneum is non-restrictive, so that benign tumors 
are often able to grow to a large size before causing symp-
toms. These are generally vague and non-specific[7], and 
range from lumbar pain and neurological symptoms in the 
lower extremities[8], to renal colicky pain, with or without 
hematuria, if  it involves the urogenital tract[9]. Abdominal 
complaints can also occur but are mainly vague and poorly 
localized, with some digestive disturbances[3,10,11]. Our 
patient’s presentation was peculiar, not only because of  
the abrupt onset of  her symptoms, but also because she 
had colitis. We believe that the tumor was large enough to 
compromise venous return in the mesocolon, which led to 
stasis characterized by the infi ltration and parietal thicken-
ing seen on CT, the edematous and erythematous aspect 
seen during colonoscopy, and the chronic inflammation 
with edema seen on histopathological examination. This 
idea has been strengthened by the fact that those signs dis-
appeared completely after removal of  the tumor.
Diagnosis is rarely made preoperatively. The mass seen 
on the CT scan showed characteristic features of  benign 
schwannoma. It was a well-demarcated, spherical, solitary 
mass and in a paravertebral position[6]. Contrast enhance-
ment homogeneity was seen because no gross cystic de-
generation or calcifi cation had yet occurred. Most authors 
agree that these features are not diagnostic. Other diagno-
ses such as paraganglioma, neurofi broma, ganglioneuroma, 
tumors of  mesodermal origin and retroperitoneal malig-
nancies, including malignant fibrous histiocytoma, lym-
phoma and liposarcoma, should be considered[12,13]. MRI 
was helpful because it has a better defi nition, multiplanar 
capabilities, and the possibility to differentiate the nature 
of  the tumor, such as solid tissue, fi brous tissue, simple or 
atypical fl uid, and blood[14]. It confi rmed the presence of  
a solid, homogeneous mass, and showed its relation to ad-
jacent structures in greater detail[6,15]. No invasive process 
was revealed and the margins were still regular, convincing 
us that the mass was benign in nature[16]. Defi nite diagnosis 
was made during histopathological examination and immu-
nohistochemistry. Microscopically, the mass showed An-
toni A (well-organised spindle cells in a palisade pattern) 
and B (less cellular, loose pleomorphic cells) areas[1,2], and 
tested intensely positive for S-100 protein, which is almost 
exclusively identifi ed within benign nerve sheath tumors[17,18]. 
CT-guided fine needle aspiration biopsy can be helpful in 
determining the origin of  a mass preoperatively, but is sel-
dom accurate[7]. Since we believed the mass was causing coli-
tis, open surgical excision was performed. Successful lapa-
roscopic removal of  retroperitoneal schwannomas has been 
reported[19], as well as with endoscopic minilaparotomy[20].
Recurrence is rare and probably due to incomplete exci-
sion[7,21]. Further investigations were performed to exclude 
schwannomatosis or NF2. Absence of  other schwannomas 
and lack of  family history of  schwannoma theoretically ex-
cluded both conditions (see diagnostic criteria in Tables 1 
and 2). The presence of  a germline NF2 mutation was ex-
cluded by a thorough genetic analysis. We performed direct 
Figure 5  Antoni A area on the right (well-organised spindle cells in a palisade 
pattern) and Antoni B area (less cellular, loose pleomorphic cells) on the left (HE, 
× 200).
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sequencing of  all coding exons of  the NF2 gene. Deletion 
was excluded by MLPA. This mutation detection strategy, 
ideally performed on the original tumor specimen, allows 
the detection of  a germline mutation in > 90% of  NF2 
patients with a family history of  the disease, and in > 70% 
of  sporadic cases. However, it is probably only justifi ed in 
sporadic unilateral vestibular schwannoma in patients aged 
< 20 years, unless other features of  NF2 are present[24].
In conclusion, benign retroperitoneal schwannomas are 
rare tumors arising from the neural sheath of  peripheral 
nerves. They are usually incidental findings but may be-
come symptomatic if  suffi ciently large. Symptoms are usu-
ally vague and non-specifi c and can mimic different diseas-
es. CT and MR fi ndings show characteristic features, but 
none are specifi c. Diagnosis is based on histopathological 
examination and immunohistochemistry. Total excision is 
therapeutic and has a good prognosis. Genetic testing for 
NF2 is probably not justifi ed in the presence of  a solitary 
retroperitoneal schwannoma.
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Table 1  Diagnostic criteria for NF2[22]
Defi nite NF2
   1 Bilateral vestibular schwannomas or
   2 Family history of NF2 (fi rst-degree family relative) plus
   a  Unilateral vestibular schwannoma at age < 30 yr, or
   b  Any two of the following: meningioma, glioma, schwannoma
       or juvenile posterior subcapsular lenticular opacities/juvenile
       cortical cataract
Presumptive or probable NF2
   1 Unilateral vestibular schwannoma at age < 30 yr plus at least one
of the following: meningioma, glioma, schwannoma or juvenile
posterior subcapsular lenticular opacities/juvenile cortical cataract
   2 Multiple meningiomas (two or more) plus
   a  Unilateral vestibular schwannoma at age < 30 yr, or
   b  One of the following: glioma, schwannoma or juvenile posterior
        subcapsular lenticular opacities/juvenile cortical cataract
Table 2  Diagnostic criteria for schwannomatosis[23]
Defi nite schwannomatosis
   1 Two or more pathologically proved schwannomas, plus
   2 Lack of radiographic evidence of vestibular schwannoma
at age > 18 yr
Presumptive or probable schwannomatosis
   1 Two or more pathologically proved schwannomas without symptoms
of eighth nerve dysfunction at age > 30 yr or 
   2 Two or more pathologically proved schwannomas in an anatomically
limited distribution (single limb or segment of the spine), without
symptoms of eighth nerve dysfunction, at any age
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